PhD candidate position M&S Neglected Tropical Diseases

We are searching for a PhD candidate for an exciting and high-impact research project on the topic of modelling and simulation of pharmacokinetics (PK) and pharmacodynamics (PD) of new drugs and drug combinations against the neglected tropical disease visceral leishmaniasis. The activities will entail pharmacometric modelling of PK and PD data to support an ongoing phase II/III clinical trial and to prepare for future clinical trials, amongst others in Eastern Africa and South Asia. The research will be executed within the Pharmacometrics group of the Pharmacy of the Antoni van Leeuwenhoek hospital - Netherlands Cancer Institute in Amsterdam, the Netherlands, and will be performed in close collaboration with the non-profit organization Drugs for Neglected Diseases initiative (DNDi). For further details, please see: https://www.nki.nl/working-at-the-nki/phd-candidate-pharmacometricsclinical-pharmacology/ or contact dr. T.P.C. Dorlo, tel. +31 20 512 4741 or e-mail: [email protected]<mailto:[email protected]>. If you are interested, please submit your application including CV and motivational letter through our website: https://www.nki.nl/working-at-the-nki/phd-candidate-pharmacometricsclinical-pharmacology/ Best wishes, Thomas Thomas P.C. Dorlo, PhD Pharmacometrician, senior researcher Dept. Pharmacy & Pharmacology Google https://scholar.google.nl/citations?user=y3J9YwIAAAAJ&hl=en | https://www.researchgate.net/profile/Thomas_Dorlo | https://se.linkedin.com/in/thomas-dorlo-70984412 t: +31 20 512 4741 e: [email protected] [cid:[email protected]] Antoni van Leeuwenhoek | Plesmanlaan 121 | 1066 CX AMSTERDAM | http://www.avl.nl/ Dit e-mailbericht is uitsluitend bestemd voor de geadresseerde(n). Als dit bericht niet voor u bestemd is, wordt u vriendelijk verzocht dit aan de afzender te melden. Het Antoni van Leeuwenhoek (AVL) staat door de elektronische verzending van dit bericht niet in voor de juiste en volledige overbrenging van de inhoud, noch voor tijdige ontvangst daarvan. Voor informatie over het AVL raadpleegt u http://www.avl.nl/. This e-mail is intended for the addressee(s) eyes only. If you are not the intended recipient, you are hereby kindly requested to inform the sender of this. In view of the electronic nature of this communication, The Netherlands Cancer Institute (NKI) is neither liable for the proper and complete transmission of the information contained therein nor for any delay in its receipt. For information about the Netherlands Cancer Institute, go to http://www.nki.nl/.